点压式数字乳腺断层合成在局灶性疼痛与可触及异常中的应用价值
本研究回顾性纳入196例因局灶性乳腺疼痛或可触及异常就诊、接受FFDBT、scDBT及靶向超声检查的女性,评估scDBT是否较标准FFDBT增加诊断价值。结果显示,两组阅片者一致性均无显著差异,scDBT未额外检出FFDBT或超声遗漏的恶性或高危病变。
要点
- 局灶性疼痛组影像异常率仅3.6%,未见恶性或高危病变。
- 可触及异常组中相当比例的可干预病变仅由超声发现。
- 可考虑在诊断流程中省略常规scDBT投照以优化流程并减少辐射。
核心结论
- 在局灶性乳腺疼痛或可触及异常的检查中,scDBT与标准FFDBT的阅片者表现无显著差异。
- 免除常规scDBT投照可改善工作流程并减少辐射暴露,而不降低诊断效能。
研究设计与样本
- 回顾性队列研究,纳入196例年龄≥30岁的女性,5年期间因局灶性乳腺疼痛(112例)或可触及异常(110例)接受FFDBT、scDBT及靶向超声检查,随访≥2年。
- 三位接受乳腺影像专科培训的放射科医生在间隔4周洗脱期后分别独立判读FFDBT与scDBT图像。
关键影像表现/征象
- 局灶性疼痛组影像检出异常率仅为3.6%,FFDBT与scDBT对有无影像异常的一致率分别为85.1%和80.1%(P=0.08)。
- 可触及异常组影像检出异常率为41.8%,FFDBT与scDBT一致率分别为63.0%和69.4%(P=0.08)。
- 多数需要干预的病变在FFDBT或超声上可见,其中相当比例仅在超声上检出。
诊断标准与关键数值
- 局灶性疼痛组FFDBT与scDBT阅片一致性分别为85.1%和80.1%(P=0.08)。
- 可触及异常组FFDBT与scDBT阅片一致性分别为63.0%和69.4%(P=0.08)。
- scDBT未检出任何FFDBT或超声未发现的恶性或高危病变。
临床应用与阅片要点
- 对于局灶性疼痛和可触及异常的诊断流程,可考虑省略常规scDBT投照。
- 靶向超声在可触及异常中的作用不可替代,相当比例的可干预病变仅由超声发现。
- 局灶性疼痛患者影像异常罕见,阅片时可适当降低过度诊断的警惕性。
局限性
- 回顾性队列研究设计。
- 阅片一致性采用P值比较,样本量可能不足以检出小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVE: To evaluate whether spot compression digital breast tomosynthesis (scDBT) adds diagnostic value beyond standard full-field digital breast tomosynthesis (FFDBT) in patients presenting with focal breast pain or palpable abnormalities.
MATERIALS AND METHODS: In this retrospective cohort study, we identified 196 women aged ≥30 years who underwent FFDBT, scDBT, and targeted ultrasound for focal breast pain (n = 112) or palpable findings (n = 110) over a 5-year period, with ≥2 years of follow-up. Three fellowship-trained breast imaging radiologists independently interpreted FFDBT and scDBT views in separate sessions with a 4-week washout period. Imaging findings, BI-RADS assessments, pathology results, and correlation with clinical outcomes were analyzed to compare diagnostic performance.
RESULTS: In the focal pain cohort, image-detected abnormalities were rare (3.6%), and agreement regarding the presence or absence of an imaging finding was high for both FFDBT (85.1%) and scDBT (80.1%, P = 0.08). No cancers or high-risk lesions were detected. Among patients with palpable findings, abnormal imaging findings were more common (41.8%), but agreement did not significantly differ between FFDBT (63.0%) and scDBT (69.4%, P = 0.08). Most actionable findings were visible on FFDBT or ultrasound, with a substantial proportion identified on ultrasound only. scDBT did not detect any malignant or high-risk lesions not already identified on FFDBT or ultrasound.
CONCLUSION: Our study found no significant difference in reader performance using scDBT compared to standard FFDBT in the workup of focal breast pain or palpable abnormalities. Based on these results, eliminating routine scDBT views for these diagnostic imaging protocols may improve workflow and reduce radiation exposure without compromising diagnostic performance.
引用
- Yoon, Soo, Wolf, et al. Spot Compression Tomosynthesis: Utility in the Workup of Focal Pain and Palpable Abnormalities. Acad Radiol. 2026. PMID: 42823315. doi:10.1016/j.acra.2026.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。